Epworth welcomes new HIV prevention drug

“We gather here to launch Lenacapavir, a long-term injectable option for HIV prevention, and to show our commitment to protecting life and ending Aids as a public health threat.”. 
By Jairos Nhakano Feb. 22, 2026

Malaria medicine shortages expose health funding crisis

The province is facing a critical shortage of frontline malaria medication and therapeutic nutritional feeds at a time when cases are surging. 
By Newsday Feb. 14, 2026

. . . as govt expands programme to enhance HIV prevention for young women

GOVERNMENT is strengthening peer-led support for adolescent girls and young women through the expansion of the Young Mentor Mother Programme, a move aimed at enhancing HIV prevention
By Staff Reporter Feb. 5, 2026

Men at risk of contracting advanced HIV: Report

MEN are at high risk of contracting advanced HIV disease, with higher Aids-related mortality recorded due to lower health-seeking behaviours, a latest report revealed. 
By Brent Shamu Feb. 5, 2026

Bloodbath as 372 pension funds face closure

Analysts said this scenario directly threatens the future benefits of thousands of employees.
By Gamuchirai Nyamuziwa Jan. 16, 2026

MC Fortue’s big mic dreams

SHE is the bride who bends gracefully to speak to her bridesmaids — a moment that has become synonymous with her unique charm as a master of ceremonies (MC).
By Tatenda Kunaka Jan. 7, 2026

Byo records decline in VMMC uptake amid STI concerns

Moyo explained that changes in policy had also altered how VMMC services are delivered, including the removal of compulsory HIV testing for men seeking circumcision.
By CITE Jan. 1, 2026

Second, third line HIV treatment numbers surge cause for concern

THE increase in second and third line HIV treatment uptake in Bulawayo is a cause for concern amid revelations there is treatment failure among uptakers. 
By Silas Nkala Dec. 31, 2025

Alarm as Bulawayo records spike in new STI cases

In the second quarter, new STI cases declined to 1 400, with the HIV positive rate remaining at 4%, while 233 contacts were treated. 
By Silas Nkala Dec. 22, 2025